November 2016
11/23/16 HSCI codirect David Scadden and HSCI Executive Committe Chair Len Zon used a multicolored cell-labeling technique to track blood stem cell development in behavior in two seperate studies. Featured: Science Daily, Harvard Gazette, News Medical, Phys.org, GEN News, Bioscience Technology
11/16/16 Magenta Therapeutics, a startup founded on the work of HSCI codirector David Scadden and HSCI Principal Faculty member Derrik Rossi with the goal of improving bone marrow transplants, recieved $48.5 million in Series A funding. Featured: Forbes, Boston Business Journal, The Boston Globe, Boston Herald, The Harvard Gazette, The Harvard Crimson, Fierce Biotech, Medical XPress, XConomy, MedCity News, Global University Venturing
11/08/2016 Joslin Diabetes Ceneter honored HSCI Principal Faculty member Gordon Weir as well as the daughters of HSCI postdoctoral fellow Quinn Peterson at its annual High Hopes Gala. Featured: The Boston Globe, Haute Living, Wicked Local Belmont, Wicked Local Cambridge
October 2016
10/20/2016 Non-profit organizations supporting research for Duchenne Muscular Dystrophy honor HSCI Principal Faculty Member Louis Kunkel at a charity event.
10/15/16 A Sweet Life highlights the work of Doug Melton and the BAIRT program as presented at HSCI's HUBweek panel.
10/08/2016 Time covers HSCI Principal Faculty member Richard Lee's work understanding the relationship between fructose consumption/absorption and diabetes.
September 2016
9/08/16 MIT News asked John Rinn, HSCI Principal Faculty member, for his expert opinion on the latest MIT research on lncRNA.
9/2/16 HSCI Principal Faculty member Amar Sahay found a way to make memories stronger and more precise. Featured: Scicasts, Science 2.0,
9/01/16 The Harvard Gazette highlights Paola Arlotta's work growing cerebral buds from iPS cells as one many exemplary innovative research projects on campus in an article about The Harvard Campaign.
August 2016
8/17/2016 AllAfrica features HSCI Principal Faculty member Kornelia Polyak's work describing the mechanisms behind why women who give birth before 30 are less likely to develop breast cancer.
8/12/16 MIT Technology Review profiled Doug Melton and detailed his work to find a cure for diabetes. The profile was reposted in Business Insider.
8/9/16 Harvard University announced George Q. Daley, HSCI Executive Committee member, will be the next dean of the Faculty of Medicine. Featured: International Business Times, Boston Business Journal, STAT, Harvard Gazette, Harvard Magazine, The Harvard Crimson, Boston.com, Becker's Hospital Review, Modern Healthcare
July 2016
7/06/16 American Museum of Natural History profiles biotechnologist and entrepreneur Jeff Karp.
June 2016
6/27/16 Bloomberg News examines the potential for growth of the regenerative medicine industry in the Japanese market, and HSCI Executive Director, Brock Reeve, provides insight to the state of the industry in the US.
6/24/16 HSCI Co-Founder David Scadden comments in a STAT article on FDA-approved (through the "compassionate use" exemption) stem cell procedure given to a lung cancer patient.
6/17/2016 HSCI Principal Faculty member George Murphy explains how cancer stem cells function within a tumor in a Science article.
6/16/16 HSCI, Brigham and Women's Hospital, Joslin Diabetes Center, and Semma Therapeutics announce an initiative, called the Boston Autologous Islet Regenerative Therapy program, to develop personalized cell-based therapies for patients with type 1 diabetes. Featured: STAT, Boston Business Journal, Boston Magazine
6/8/16 NPR profiles Kit Parker, HSCI Principal Faculty member, focusing on how his friendship with Army buddy Chris Moroski influenced his decision to start studying traumatic brain injury.
6/7/16 HSCI Co-Director David Scadden uses antibodies, rather than the standard treatment of chemotherapy and radiation, in a new approach to make bone marrow transplant procedures safer and less/toxic. Featured: Harvard Gazette, News-Medical, Science Daily, Scicasts, ScienceCodex, Medical XPress
6/6/16 Ole Isacson talks about Parkinson's disease risk factors, in the wake of Muhammad Ali's death. Featured: WNYC and Public Radio International, USA Today, ABC, Record Searchlight
May 2016
5/27/16 Stuart Orkin writes about the economics of gene therapy development and the determination of cost and mark value in Science online.
5/11/16 The Melton Lab makes beta-producing cells from iPSCs derived from diabetic patients. Featured: Scicasts, Science Daily, Bioscience Technology, R&D Magazine, IBC World News, The Free Press Journal, Washington News Wire, Health Canal
5/11/16 A Tablet article about the science of aging highlights the work of HSCI Principal Faculty members Amy Wagers, Rich Lee and Lee Rubin, and HSCI Executive Director, Brock Reeve, provides context about the economic landscape of diseases of aging.
5/10/16 Chad Cowan, HSCI Principal Faculty member, speaks to Medscape about the history of stem cells and the future of medicine.
5/6/16 In a CBS Boston special report, HSCI Co-Director David Scadden comments on the exploitative nature of stem cell clinics offering untested therapies.
April 2016
4/06/16 HSCI Principal faculty member Kornelia Polyak identifies a molecular marker in healthy breast tissue that may help doctors asses a woman's risk of getting breast cancer. Featured: Harvard Gazette, Tech Times, Science Daily, R&D Magazine, Daily News and Analysis, Science Codex, Medical XPress
4/01/16 Healio covers Doug Melton, HSCI founding co-director, speech at the Endocrine Society's 98th annual meeting about his hope to one day replace insulin injections with cell therapy for diabetics.
March 2016
3/25/16 Les Silberstein, an HSCI Principal Faculty member, explained to Medical Daily why A/B blood types are rare.
3/16/15 HSCI Principal Faculty member Harald Ott grows a life-size, beating human heart from stem cells. Featured: Popular Science, Huffington Post, Albany Daily Star, Co.Exist, Science Alert
February 2016
2/29/2016 George Q. Daley, HSCI Executive Committee member, questions the STAP process of making stem cells, effectively debunking the work. He describes that journey in a New Yorker article.
2/05/16 As a guest on the Science Friday podcast, HSCI Executive Committee member George Q. Daley details the scientific, ethical, and legal aspects of the U.K.'s Human Fertilization and Embryology Authority's decision to allow researchers to use CRISPR-Cas9 gene-editing in human embryos.
2/02/16 Jeffrey Macklis, HSCI Executive Committee member, finds a new drug target for Rett syndrome. Featured: Harvard Gazette, Science Daily, Neuroscience News, Medical XPress, Drug Discovery and Development, Scicasts, Neural Cell News